SCAI Issues Guidelines for PFO Management, Makes Case for Expansion
Clinical guidelines address expanded indications for percutaneous patent foramen ovale closure along with antiplatelet and anticoagulation therapy.
Stay updated with breaking news from Recurrent Stroke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinical guidelines address expanded indications for percutaneous patent foramen ovale closure along with antiplatelet and anticoagulation therapy.
An advisory from the American Academy of Neurology on preventing recurrent stroke in symptomatic intracranial atherosclerosis recommends antiplatelets and statins but advises against stenting.
Although dual antiplatelet therapy using cilostazol is associated with a lower risk of recurrent stroke in men, it has no significant benefit for women, a sub-analysis of CSPS.com results suggests.
A retrospective analysis suggests that recent NOAC use is not associated with increased risk for symptomatic intracranial hemorrhage after treatment with IV alteplase for acute ischemic stroke.
The easy-to-use scoring system will allow clinicians to stratify patients with the infection by their level of risk.